BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu HS, Jiang H, Li MK, Yang BL, Smayi A, Chen JN, Wu B, Yang YD. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World J Gastroenterol 2023; 29(35): 5166-5177 [PMID: 37744292 DOI: 10.3748/wjg.v29.i35.5166]
URL: https://www.wjgnet.com/1007-9327/full/v29/i35/5166.htm
Number Citing Articles
1
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansionWorld Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
2
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
3
Yuhua Gao, Mingyang Wang, Xia’nan Liu, Benjamin M. Liu. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferaseMicrobiology Spectrum 2024; 12(4) doi: 10.1128/spectrum.03941-23
4
Hongsheng Yu, Yinan Huang, Mingkai Li, Hao Jiang, Bilan Yang, Xiaoli Xi, Abdukyamu Smayi, Bin Wu, Yidong Yang. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver diseaseJournal of Gastroenterology and Hepatology 2024; 39(10): 2169 doi: 10.1111/jgh.16673